Initial Dosing of Paricalcitol in Secondary Hyperparathyroidism
Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to compare two different initial dosing schemes for the
administration of paricalcitol in hemodialysis patients with secondary hyperparathyroidism:
the already in use iPTH/80 scheme, and an iPTH/120 scheme, which corresponds to the
immediately lower dose, based on current instructions on paricalcitol dose adjustment. We
studied the effectiveness of the two dosing schemes in achieving a target iPTH level (150 -
300 pg/mL)